Imbio PHA (4.0.0) vs 1CMR Pro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Imbio PHA (4.0.0)

by Imbio (a subsidiary of 4DMedical)

1CMR Pro

by Mycardium AI Limited

AI Verdict

Imbio PHA specializes in automated cardiac measurements from CT pulmonary angiogram (CTPA) scans, aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension. In contrast, 1CMR Pro enhances Cardiac MRI reporting by providing more precise volumetric and functional measurements. While both are AI-powered tools for cardiac imaging analysis, their distinct input modalities and specific clinical applications make them complementary rather than direct competitors.

Choose Imbio PHA (4.0.0) if…

Choose Imbio PHA (4.0.0) if your primary need is rapid, automated assessment of cardiac structures from CT pulmonary angiogram (CTPA) scans. This tool is ideal for aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension by quickly identifying right ventricular dilation and seamlessly integrating into existing DICOM workflows for acute care settings.

View Imbio PHA (4.0.0) →

Choose 1CMR Pro if…

Choose 1CMR Pro if your institution performs Cardiac MRI and requires highly precise, reproducible, and automated volumetric and functional measurements for comprehensive cardiac assessment. This on-premise solution is best suited for cardiologists and radiologists seeking to enhance the accuracy and consistency of their CMR reporting, particularly when local data processing and the ability to review and edit AI-generated contours are critical.

View 1CMR Pro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Imbio PHA (4.0.0)	1CMR Pro
Pricing	Unknown	Contact for pricing
Deployment	Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel).	On-premise (software installed on hospital's own computer, processing data locally via a secure web-based platform)
FDA Status	Yes AI-estimated	Cleared AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Imbio PHA (4.0.0)	1CMR Pro
Name	Imbio PHA (4.0.0)	1CMR Pro
Company	Imbio	Mycardium AI Limited
Primary Imaging Modality	CT pulmonary angiogram (CTPA) scans	Cardiac MRI
Key Measurements/Functionality	Automated measurement of right and left ventricle diameters, main pulmonary artery and aorta diameters; Calculates RV/LV and PA/Ao ratios; Generates annotated DICOM images and PDF reports.	AI-enhanced Cardiac MRI Reporting; Automated volumetric and functional measurements; Transparent and editable contours; Regulatory-grade automation for precision and reproducibility.
AI Training Data	Not specified	Convolutional neural networks trained on extensive datasets (700,000 cine images, 60,000 expert segmentations)
Data Processing Location	Not specified	Local data processing (no patient data transmitted beyond institution)

Videos

Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and 1CMR Pro.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What types of medical images do these AI tools analyze?

Imbio PHA (4.0.0) is designed to process CT pulmonary angiogram (CTPA) scans to measure cardiac structures. In contrast, 1CMR Pro by Mycardium AI is an AI-enhanced reporting software that analyzes Cardiac MRI data.

What specific clinical conditions or assessments are these tools designed to aid in?

Imbio PHA (4.0.0) assesses potential right ventricular dilation and aids in the diagnosis and risk stratification of pulmonary embolism and hypertension. 1CMR Pro focuses on delivering faster and more consistent cardiac MRI analysis by providing automated volumetric and functional measurements, with up to 40% more precise measurements.

What regulatory clearances do these AI tools possess?

Both tools are FDA-cleared. Imbio PHA (4.0.0) is an FDA-cleared AI-powered medical image processing software. 1CMR Pro is FDA 510(k) cleared and also holds CE Class IIB clearance.

What specific measurements and outputs do these tools provide?

Imbio PHA (4.0.0) automatically measures right and left ventricle diameters, main pulmonary artery and aorta diameters, and calculates RV/LV and PA/Ao ratios, generating annotated DICOM images and PDF summary reports. 1CMR Pro provides AI-enhanced cardiac MRI reporting with automated volumetric and functional measurements, including left and right ventricular volumes and function, as well as atrial areas and strain parameters.

Do these tools offer quantifiable improvements in measurement precision or analysis speed?

1CMR Pro claims to deliver up to 40% more precise measurements than manual analysis, enabling faster and more consistent cardiac MRI analysis. Imbio PHA (4.0.0) offers rapid, fully-automated assessment, typically providing results in minutes.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform